obesity drugs

weight loss scale weigh measure tape obesity overweight
Biotech

Pfizer’s new prize Metsera touts 14% weight loss for GLP-1

The drug at the center of Pfizer’s buyout has been tied to 14.1% weight loss at 28 weeks as well as “potentially class-leading tolerability.”
James Waldron Sep 30, 2025 6:40am
cancel

Lilly withdraws phase 2 obesity trial before starting enrollment

Sep 25, 2025 8:07am
Measuring tape on top of cash

Pfizer inks $4.9B Metsera buyout to beef up obesity pipeline

Sep 22, 2025 7:47am
obesity overweight weight loss weigh

QL Biopharm links monthly GLP-1 to incumbent-rivaling efficacy

Sep 18, 2025 7:20am
Measuring tape on top of cash

Novo seeks obesity refresh with $550M Replicate deal

Aug 28, 2025 7:00am
frozen cold viking long boat winter snow

Viking hits stormy seas as phase 2 oral obesity data sink stock

Aug 19, 2025 9:44am